BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2015 10:38:00 AM | Browse: 1088 | Download: 1967
 |
Received |
|
2014-10-30 08:29 |
|
Peer-Review Started |
|
2014-10-30 16:21 |
|
To Make the First Decision |
|
2014-11-26 18:20 |
|
Return for Revision |
|
2014-12-04 17:01 |
|
Revised |
|
2014-12-09 10:06 |
|
Second Decision |
|
2015-01-28 14:08 |
|
Accepted by Journal Editor-in-Chief |
|
2015-01-28 14:13 |
|
Accepted by Executive Editor-in-Chief |
|
2015-01-30 15:40 |
|
Articles in Press |
|
2015-01-30 18:32 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2015-02-27 20:32 |
|
Typeset the Manuscript |
|
2015-04-20 09:36 |
|
Publish the Manuscript Online |
|
2015-05-13 10:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun Gao, Shao-Hong Wang, Xue-Mei Ding, Wen-Bing Sun, Xiao-Long Li, Zong-Hai Xin, Chun-Min Ning and Shi-Gang Guo |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Dr. Jieping Wu Medical Foundation |
320675007131 |
| Dr. Jieping Wu Medical Foundation |
32067501207 |
| Clinical-Basic Medicine Cooperation Fund of Capital Medical University |
1300171711 |
| Program for Medical Key Discipline of Shijingshan District |
20130001 |
|
| Corresponding Author |
Wen-Bing Sun, MD, Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China. cyhswb@qq.com |
| Key Words |
Hepatocellular carcinoma; Radiofrequency ablation; Therapeutic efficacy; Safety; Survival |
| Core Tip |
The argument against the role of radio?frequency (RF) ablation as a first treatment option for patients with small hepatocellular carcinoma (HCC) is represented by the lack of adequate evidence proving that its effectiveness is comparable to that of surgical resection (SR). The study provides evidence that RF ablation is a safe and effective first-line treatment for single HCC 3 cm or less, even when SR is possible. Furthermore, we also induced the systemic technical measures to promote the efficacy of RF ablation for HCC from the surgeon’s perspective. |
| Publish Date |
2015-05-13 10:38 |
| Citation |
Gao J, Wang SH, Ding XM, Sun WB, Li XL, Xin ZH, Ning CM, Guo SG. Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment. World J Gastroenterol 2015; 21(17): 5287-5294 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i17/5287.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i17.5287 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
